Narmada Shenoy

RCA (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index17.2kcitations25works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chemical Synthesis and Analysis(5), Gut microbiota and health(4), Angiogenesis and VEGF in Cancer(3), Carbohydrate Chemistry and Synthesis(3), Peptidase Inhibition and Analysis(3)

Publications21 total

RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease
Molecular Pharmacology·2017· 54 citedOpen Access
Lifestyle transitions in plant pathogenic Colletotrichum fungi deciphered by genome and transcriptome analyses
Nature Genetics·2012· 1.0k citedOpen Access
Insights into evolution of multicellular fungi from the assembled chromosomes of the mushroom <i>Coprinopsis cinerea</i> ( <i>Coprinus cinereus</i> )
Proceedings of the National Academy of Sciences·2010· 412 citedOpen Access
Development of an intravenous formulation of SU010382 (prodrug of SU5416, an anti-angiogenesis agent).
PubMed·2008· 6 cited
High-performance liquid chromatographic method for determination of reversible isomers of SU5416
Journal of Chromatography A·2006· 8 cited
Bioinformatics Analysis and Annotation of Microtubule Binding and Associated Proteins (MAPs) - Creating a Database of MAPs
IUScholarWorks (Indiana University)·2005Open Access
Reversible Z-E Isomerism and Pharmaceutical Implications for SU5416
Drug Development and Industrial Pharmacy·2005· 10 cited
Powder‐in‐Bottle Formulation of SU011248. Enabling Rapid Progression into Human Clinical Trials
Drug Development and Industrial Pharmacy·2004· 18 cited
Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies.
PubMed·2003· 288 cited
Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitors
Blood·2002· 124 citedOpen Access
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.
PubMed·2000· 497 cited
Growth inhibition of psoriatic keratinocytes by quinazoline tyrosine kinase inhibitors
British Journal of Dermatology·1999· 46 cited
Studies in C-terminal sequencing: New reagents for the synthesis of peptidylthiohydantoins
Journal of Protein Chemistry·1993· 10 cited
Automated carboxy‐terminal sequence analysis of peptides and proteins using diphenyl phosphoroisothiocyanatidate
Protein Science·1992· 30 citedOpen Access
Nitrosation of piperine using different nitrosating agents: characterization and mutagenicity of the products
Journal of Agricultural and Food Chemistry·1992· 3 cited
Inhibitory effect of diet related sulphydryl compounds on the formation of carcinogenic nitrosamines
Cancer Letters·1992· 72 cited
Characterization of potentially mutagenic products from the nitrosation of piperine
Cancer Letters·1992· 9 cited
Automated C-Terminal Sequencing of Peptides
Elsevier eBooks·1992· 1 cited
Automated carboxy‐terminal sequence analysis of peptides
Protein Science·1992· 33 citedOpen Access
Carboxylic acid‐modified polyethylene: A novel support for the covalent immobilization of polypeptides for C‐terminal sequencing
Protein Science·1992· 22 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Jerome M. Bailey(5), John E. Shively(5), Ahmed S. U. Choughuley(4), Anand Sistla(4), Gerald McMahon(3), Julie M. Cherrington(3), Bruce W. Birren(2), Qiandong Zeng(2), Li‐Jun Ma(2), Laura K. Shawver(2), Cho Tang(2), Cheryl A. London(2), May Chien(2), Dirk B. Mendel(2), Richard J. O’Connell(1), Michael R. Thon(1), Stéphane Hacquard(1), Stefan G. Amyotte(1), Jochen Kleemann(1), María Fernanda Torres(1)